Illiquidity Discount Applied in Addition to Company-Specific Risk Adjustment in the Capitalization Rate

Business Valuation Update BVLaw
Legal and Court Case Update
November 9, 2000

Access the Full Article

This article is available with a subscription to any of these products:
Already a subscriber?  Login
This article is also available for purchase. (746 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2833 Medicinal Chemicals and Botanical Products
325411 Medicinal and Botanical Manufacturing
judicial dissolution
Matter of Wolk v. Vetco, Inc.
NYLJ, November 9, 2000
US
State Court
New York
Supreme Court
Lynda Davey <br> Douglas Land <br>
Gibson

Summary

The New York Supreme Court valued an over-the-counter pharmaceutical company for a buyout under BCL sec 1118.

See Also

Matter of Wolk v. Vetco, Inc.

Full Text of Court Cases
November 9, 2000

The New York Supreme Court valued an over the counter pharmaceutical company for a buyout under BCL sec 1118. The court rejected valuations using the liquidation and analytic pricing models, and accepted a valuation of the business using the capitalizatio ...